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Abstract MPTP6 is a murine transmembrane protein tyrosine phosphatase which has three isoforms, types A-C, differing in the structure of the 
extracellular regions. In this study, we examined MPTP~ isoform expression in the brain and the immune system at discrete developmental or
differentiation stages. RT-PCR analysis demonstrated that another isoform, type D, is transcribed from the MPTP~ gene. In\the brain, only type 
D was expressed until postnatal day 7 (P7), but after P14, all four isoforms were detected. In contrast, he spleen, thymus and all the hematopoietic 
cell lines examined express only types B and C isoforms. An in situ hybridization study showed that MPTP6 mRNA is diffusely expressed throughout 
the spleen, but its expression i  the thymus is restricted to the medullary region. 
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1. Introduction 
Protein tyrosine phosphorylation plays a central role in the 
regulation of normal cell activation, proliferation and differen- 
tiation [1-3]. The phosphorylation state of tyrosine residues on 
cellular proteins is strictly controlled by protein tyrosine ki- 
nases (PTKs) and protein tyrosine phosphatases (PTPs) under 
physiological conditions. While a number of PTKs, identified 
as growth factor receptors and oncogene products, are well 
characterized, the understanding of structure and function of 
PTPs has been very limited. In 1988, it was demonstrated that 
the cytoplasmic region of CD45, a transmembrane molecule on 
the hematopoietic cells, has a sequence similar to a cytoplasmic 
PTP (PTP1B) [4] and has intrinsic PTP activity [5]. Since then, 
more than 40 PTPs have been cloned from various species and 
tissues using either cross-hybridization r a polymerase chain 
reaction (PCR) technique based on the sequence similarity of 
the consensus equences in the PTP domains [6,7]. They are 
classified into two groups: soluble-form PTPs with a single PTP 
domain, and transmembrane PTPs (also referred to as recep- 
tor-type PTPs; RPTPs), almost all of which contain two PTP 
domains in the cytoplasmic regions. 
Based on the structural diversity of the extracellular region, 
RPTPs have been subdivided into four groups by Fischer et al. 
[8]. Among them, type II RPTPs are characterized by the pres- 
ence of varying numbers of immunoglobulin (Ig)-like and fi- 
bronectin type III repeat (FN-III)-like domains in the extracel- 
lular regions and include LAR [9,10], PTP6 [11,12], PTPx [13], 
PTP/t [14], PTPa (NE-3) [15,16] and Drosophila DPTP [10]. 
Since these structural motifs are also utilized by cell adhesion 
molecules uch as the neural cell adhesion molecule (N-CAM), 
it has been postulated that type II RPTPs might be involved in 
cell adhesion. Indeed, PTPlc and PTP/2 were shown to mediate 
homophilic ell adhesion when expressed in insect cells using 
recombinant baculovirus expression systems [17-19]. However, 
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physiological ligands of type II RPTPs and how the binding of 
ligands influences the PTP activity still remain to be clarified. 
It is well known that several PTKs, such as the src-family of 
PTKs, are abundantly expressed in the central nervous sys- 
temm [20-23] and the immune system (reviewed in [3]). The 
receptors for nerve growth factor and several neurotropic fac- 
tors have intrinsic PTK activity [24-27]. In the immune system, 
soluble-form PTKs have been shown to be associated with 
antigen receptors (reviewed in [3]) and growth factor receptors 
[28]. All these observations suggest hat protein phosphoryla- 
tion is involved in the signal transduction for cell activation and 
proliferation. In addition, tyrosine phosphorylation was dem- 
onstrated to be modulated uring the development of the cen- 
tral nervous ystem [29]. To analyze the mechanisms of regula- 
tion during differentiation from the perspective of PTPs, we 
have recently cloned and characterized a mouse type II RPTP, 
named MPTP~. The MPTP6 gene is expressed in the special- 
ized regions of the brain and in B cells, which shows a high 
degree of sequence similarity to LAR and PTPa, and generates 
at least three isoforms differing in the extracellular region pos- 
sibly by an alternative splicing mechanism [12]. Type A is com- 
posed of one Ig-like and four FN-III-like domains; the type B, 
one Ig-like and eight FN-III-like domains; and the type C, three 
Ig-like and eight FN-III-like domains [12] (Fig. 1). 
To elucidate the functional roles of MPTP~ in the central 
nervous system and the immune system, we tried to examine 
the expression of MPTP~ at discrete developmental or matura- 
tional stages by reverse transcription (RT)-PCR using isoform- 
specific primers, and to determine the localization of the 
MPTP6 gene expression within the lymphoid organs by in situ 
hybridization. The results herein demonstrated that the 
MPTP~ gene generates another isoform, the extracellular re- 
gion of which is composed of three Ig-like and four FN-III-l ike 
domains, that the spleen, thymus and all the hematopoietic cell 
lines tested express types B and C MPTP6 isoforms, and that 
in the brain, the expression of MPTP6 isoforms is developmen- 
tally regulated. Furthermore, MPTP6 mRNA is mainly ex- 
pressed in the medulla of the thymus and only sparsely in the 
cortex. All these results suggest that MPTP~ may be involved 
in the regulation of differentiation and maturation of the brain 
and lymphocytes. 
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2. Materials and methods 
2.1. Cell lines and culture conditions 
The following cell lines were used in this study: pro-B cell line NFS- 
70; pre-B cell lines NFS-5, NFS-25, and 70Zl3; surface Ig-positive Bcell 
lines WEHI-231, 1-29, WEHI-279, BAL-17, CHI, X16C8.5, and A-20; 
myeloma cell line P3U1; antibody-producing hybridoma 3-3.1; T cell 
lines EL-4 and RL61; and macrophage lines P388D.I and J774. All of 
the cell lines were cultured in RPMI1640 (Nikken Bio Medical Labora- 
tory, Kyoto, Japan) supplemented with 10% heat-inactivated fetal bo- 
vine serum, 2-mercaptoethanol (50pM), streptomycin (100,ug/ml) and 
penicillin (100 U/ml) at 37°C in a humidified atmosphere of 5% CO2 
and 95% air. 
2.2. Mice 
Brain, thymus and spleen from adult female and time-pregnant fe- 
male SJL mice and their litters were used. Successful copulation was 
determined by the presence of a vaginal plug and recorded as embryonic 
day 0 (E0). The day of birth was recorded as postnatal day 1 (P1). 
2.3. RT-PCR 
Total cellular RNA was prepared using the single-step acid guanid- 
ium thiocyanate method. For the first strand cDNA synthesis, 10/zg 
of total RNA was heated at 70°C for 5 min, then 40 pmol of specific 
Y-antisense primer (5'-AGCACTGTTCCCACGATTGGT-3') or 
oligo (dT) primer, dNTP (10 mM), reverse transcription buffer and 
human placental ribonuclease inhibitor (Toyobo, Osaka, Japan) were 
added together with 200 U of Moloney murine leukemia virus reverse 
transcriptase (BRL, Gaithersburg, MD) in a final volume of 20,ul. The 
reaction mixture was incubated at 42°C for 2 h. The synthesized cDNA 
was directly used as a template for subsequent PCR amplification. The 
following four sets of primers pecific for each domain of MPTP6 were 
used (see Fig. 2): for one Ig-like domain (types A and B), 5"-CAGA- 
CCATACTTGTACGG-Y (sense, primer 1), and 5'-CTGGGCTATT- 
GCTTCAAT-3' (antisense, primer 2); for three Ig-like domains (types 
C and D), 5'-GAGACACCCCCCAGGTTT-Y (sense, primer 8), and 
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Fig. 1. Schematic representation of the structures of the MPTP5 
isoforms. Open boxes indicate the putative signal peptides (S) and the 
transmembrane peptides (TM). Stippled and hatched boxes indicate the 
Ig-like and FN-lII-like domains, respectively. In addition, densely stip- 
pled and hatched boxes indicate the first and the second insertions as 
described in [12], respectively. Solid boxes indicate PTP domains. 
5'-CGGATTACCGCTGGCTGC-Y (antisense, primer 9); for four 
FN-III-like domains (types A and D), 5'-TTCCGTCTGTCTGCAAC- 
G-Y (sense, primer 3) and 5'-ATCCACTTCTTCCACCAT-3' (anti- 
sense, primer 4); for eight FN-III-like domains (types B and C), 
5'-TCGGATACTACCAAGTAC-3' (sense, primer 6) and 5'-GCCTT- 
CTGAGTG GAGGTT-3' (antisense, primer 7). To detect he expres- 
sion of each MPTP~ isoform, the following combinations of primers 
were used (Fig. 2): for type A, primers 1 and 4; for type B, primers 1 
and 7; for type C, primers 8 and 7; for type D, primers 8 and 4. For 
the internal control, oligo (dT)-primed cDNA was amplified with glyc- 
eraldehyde 3-phosphate dehydrogenase (GAPDH)-specific primers 
(Clonetech, Palo Alto, CA). The PCR products were subsequently 
electrophoresed on 1% agarose gels, transferred onto a Nytran mem- 
brane (Schleicher & Schuell, Dassel, Germany), and hybridized to 32p. 
labelled probes. The following cDNA fragments were amplified by 
PCR using previously isolated cDNA clones as templates and used as 
probes for each domain and isoform (Fig. 2): for one Ig-like domain 
and types A and B, a 432-bp fragment amplified with primers 1 and 2; 
for three Ig-like domains and types C and D, a 399-bp fragment ampli- 
fied with primers 8 and 9; for four FN-III-like domains and types A 
and D, a 216-bp fragment amplified with primers 3 and 4; and for eight 
FN-III-like domains and types B and C, a 756-bp fragment amplified 
with primers 6 and 7. 
2.4. In situ hybridization 
In situ hybridization was carried out according to the previously 
described protocol [12] except for the use of digoxigenin (DIG)-11-UTP 
(Boehringer-Mannheim, Mannheim, Germany) for cRNA labelling. 
The cRNA probe corresponding toa part of the MPTP~ extracellular 
region reacted with all the isoforms. A sense RNA probe was used as 
the control. After hybridization and washing, the slides were incubated 
with alkaline phosphatase-labelled anti-DIG antibody (Boehringer- 
Mannheim, Mannheim, Germany) overnight and hybridized signals 
were visualized with Nitroblue tetrazolium salt and 5-bromo-4-chloro- 
3-indolyl-phosphate. 
3. Results and discussion 
Since the MPTP~ gene is abundantly expressed in the adult 
mouse brain [12], we first examined the expression of MPTP6 
isoforms in the brain at discrete developmental stages by RT- 
PCR. In the brain from El6  to P7, only the 399-bp fragment 
with primers 8 and 9 (for three Ig-like domains) and the 216-bp 
fragment with primers 3 and 4 (for four FN-II I - l ike domains) 
were detected (Fig. 3). This suggests that the extracellular por- 
tion of MPTP~ expressed in the brain during this period ap- 
pears to be composed of three Ig-like and four FN-II I- l ike 
domains. To confirm that this MPTPg isoform is in fact tran- 
scribed, RT-PCR was performed using primers 8 and 4. As 
shown in Fig. 4, only the 1,866-bp fragment was detected in the 
brain from E l6  to adult. Since we could not identify the isoform 
having three Ig-like and four FN-II I - l ike domains in the ex- 
tracellular egion by the cDNA cloning [12], we regarded it as 
another isoform and termed type D (Fig. 1). In the brain after 
P14, however, the PCR fragments that corresponded to the one 
and three Ig-like and the four and eight FN-II I- l ike domains 
could be detected (Fig. 3). To identify the MPTP5 isoforms 
expressed in the brain after P14, we used isoform-specific com- 
binations of primers (Fig. 2) for RT-PCR analysis and demon- 
strated that all four isoforms are detected (Fig. 4). These results 
indicate that the brain expresses all four isoforms, types A-D,  
after P14. Since exon/intron organization of MPTP~ gene has 
not been characterized, it is formally possible that the primers 
used in this study might amplify the DNA fragments of corre- 
sponding size from the contaminated genomic DNA. However, 
this possibility seems to be unlikely because no DNA fragments 
were detected when total cellular RNA from each sample was 
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Fig. 2. Schematic representations of primers used in this study and expected PCR products for each MPTP8 isoform and each domain. All boxes 
and a thick line indicate the protein-encoding re ion and thin lines indicate the 5'-untranslated region. Stippled and hatched boxes indicate the Ig-like 
and FN-III-like domains, respectively. Open boxes at the 5'- and Y-ends indicate the putative signal peptides and TM, respectively. The cDNA 
fragments which were generated by PCR using previously isolated cDNA clones as templates were used for probes to detect isoform-specific or 
domain-specific PCR products and are expressed asthick lines: probe a, for types A and B MPTP8 isoforms and one Ig-like domains; probe b, for 
types C and D isoforms and three Ig-like domains; probe c, for types A and D isoforms and four FN-III- like domains; and probe d, for types B 
and C isoforms and eight FN-III-like domains. 
directly used as a telr/plate for PCR amplification (data not 
shown). 
It has been reported that although N-CAM has five Ig-like 
domains, only the two most amino-terminal Ig-like domains are 
involved in the homophilic binding [30], that the migration of 
neurons in developing rat cerebellum is linked to the expression 
of another Ig superfamily of the cell adhesion molecule, Ng- 
CAM [31,32], and that in Drosophila, three molecules of the Ig 
superfamily, namely fasciclin II, fasciclin III, and neuroglican, 
are expressed not only during neurogenesis but also after the 
nervous ystem is completely established [33]. Thus, it may be 
that MPTP$ with three Ig-like domains are required for the 
migration of neurons or the synapse formation during neuro- 
genesis. Given that neurogenesis is almost completed by P14, 
it is reasonable toassume that strong binding with three Ig-like 
domains is not required after P14 except for the sites where the 
neural architecture should be firmly maintained, and isoforms 
with one Ig-like domain are possibly generated by alternative 
splicing. However, the precise physiological meaning of the 
MPTPd isoform alteration during neuronal development re- 
mains to be clarified. 
Next, we tried to identify the MPTP~ isoforms expressed in 
the immune system. In the previous tudy using Northern blot 
analysis [12], it was shown that although MPTPd mRNA is not 
detected in the lymphoid organs, three pre-B cell lines and one 
surface-IgG-positive B cell line express MPTP~ mRNA. As 
shown in Fig. 5, RT-PCR analysis demonstrated that one and 
three Ig-like and eight FN-III-like domains are detected in the 
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Fig. 3. Expression of MPTP6 extracellular domains in the brain exam- 
ined by RToPCR analysis. The first strand cDNA was synthesized from 
10 pg of total cellular RNA with MPTP6-specific antisense primer and 
subjected to PCR with each domain specific primers. To estimate the 
amount of mRNA and the efficiency of the first strand cDNA synthesis, 
we used GAPDH-specific primers for the amplification of oligo d(T)- 
primed cDNA. PCR products were electrophoresed on 1% agarose gels, 
transferred to Nytran membranes and probed with 32p-labelled cDNA 
probe specific for each domain. The size of PCR products for one 
Ig-like, three Ig-like, four FN-III-like and eight FN-III-like domains 
were 432 bp, 399 bp, 216 bp, and 756 bp, respectively. Brain RNAs from 
El6, El8, El9, P1, P7, PI4, P28 and adult mice were used. The size of 
each PCR product is indicated on the right. 
thymus and the spleen from P1 to adult, indicating that B and 
C isoforms are expressed. The level of the MPTP6 expression 
was almost identical throughout the maturational stages. Simi- 
larly, all the hematopoietic cell lines tested appeared to express 
both B and C MPTP6 isoforms (Fig. 6). A slightly larger frag- 
ment was found in the blots of the eight FN-I I I - l ike domains 
(lanes 11-16) but it was confirmed by sequence analysis to be 
an artificial PCR product due to cross-amplification. As in the 
case of the brain, it was confirmed by use of the isoform-specific 
combinations of primers (Fig. 2) that both types B and C 
MPTP6 isoforms are expressed in the lymphoid organs and 
hematopoietic cell lines (data not shown). Thus, the MPTPfi 
isoforms with eight FN-II I- l ike domains are preferentially ex- 
pressed in the immune system. The reason for the absence of 
isoforms with four FN-II I- l ike domains is not known. 
Since the thymus and the spleen were shown to express 
MPTP6 mRNA by the RT-PCR study (Fig. 5), localization of 
the MPTP6 expression in these tissues was examined by in situ 
hybridization using cRNA probes. The results demonstrated 
that MPTPfi signals are diffusely identified in the spleen with 
slightly heavier labelling in the follicular regions (Fig. 7A). In 
the thymus, the MPTP6 expression was detected mainly in the 
medullary region and only sparsely in the cortex (Fig. 7C). No 
specific hybridization was observed in the sections hybridized 
with a sense cRNA probe (Fig. 7B and D). Since T cells are 
known to migrate from the cortex to the medulla during matu- 
ration, it is possible that MPTP6 constitutes a critical regula- 
tory element for T cell maturation and differentiation. 
In summary, we examined the expression pattern of the 
MPTP6 isoforms in the central nervous ystem and the immune 
GAPDH - ~ ~ ;  - 1000 
Fig. 4. Expression of MPTP6 isoforms in the brain examined by RT- 
PCR analysis. The same cDNA as described in Fig. 3 was subjected to 
PCR reaction with the following sets of primers: for type A MPTP6 
isoform, primers 1 and 4; for type B isoform, primers 1 and 7; for type 
C isoform, primers 8 and 7; and for type D isoform, primers 8 and 4 
(Fig. 2). PCR products were electrophoresed, transferred to Nytran 
membranes and probed with the 3=p-labelled cDNA probe specific for 
each isoform. Probes a and b (Fig. 2) were used in this study to detect 
types A and B and types C and D, respectively. The same results were 
obtained when probes c and d (Fig. 2) were used to detect ypes A and 
D and types B and C, respectively. The size of each PCR product is 
indicated on the right. 
system. The results demonstrated that in the brain, the isoform 
expression seems to be regulated in a developmental stage- 
specific manner. Although an MPTP6 isoform change was not 
detected uring the course of lymphocyte differentiation, the 
restricted expression of MPTP8 within the thymus suggests the 
possible involvement of MPTP6 in T cell maturation. Thus, 
MPTP6 may serve as a valuable indicator for the analysis of 
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Fig. 5. Expression of MPTP6 extracellular domains in the thymus and 
the spleen examined by RT-PCR analysis. RNAs from thymus and 
spleen of P1, P7, P14, P28 and adult mice were used for RT-PCR. The 
size of each PCR product is indicated on the right. 
K. Mizuno et al./FEBS Letters 355 (1994) 223-228 227 
1 Ig -  
A 
I= 
~"  o "O 
- - -  ":- T cell Me  m pre-B slg-positive B E o
JO 
g i ii,_ ~ i ~ ~ i i l~ l  
t'~ I",- tO o ,r.-- 
432 
bp 
3 Ig -  --~ 0~ ~ - 399 
4 FN-  - 216 
m ~ i~ ~ 8 FN ~ ~,  ,, , ,~0~ 
GAPDH - - 1000 
Fig. 6. Expression of MPTPd; extracellular domains in the hematopoietic cell lines examined by RT-PCR analysis. RNAs from the following cell 
lines were used for RT-PCR: pro-B cell line NFS-70; pre-B cell lines NFS-5, NFS-25 and 70Z/3; surface Ig-positive B cell lines WEHI-231, 1-29, 
WEHI-279, BAL-17, CH1, X16C8.5 and A-20; myeloma cell line P3U1; antibody-producing hybridoma 3-3.1; T cell lines EL-4 and RLd 1; and 
macrophage lines P388D.1 and J774. The size of each PCR product is indicated on the right. 
the regulatory mechanisms of differentiation and maturation i  
the central nervous ystem and in the immune system. To firmly 
establish the physiological roles of MPTPt~, it will be necessary 
to analyze the MPTP& isoform expression at the protein level, 
to identify the ligand(s) for each isoform and to understand the 
regulation of PTP activity upon ligand binding. Studies to this 
end are currently in progress. 
Acknowledgements: We are grateful to Dr. Tomoyuki Ichikawa and 
Ms. Kyoko Ajiki for technical advice on in situ hybridization. This 
work was supported in part by grants from the Ministry of Education, 
Science and Culture, the Immunodiagnostic Laboratory, and the 
Tokyo Biochemical Research Foundation. 
References 
[1] Ullrich, A. and Schlessinger, J. (1990) Cell 61,203-212. 
[2] Schlessinger, J. and Ullrich, A. (1992) Neuron 9, 383-391. 
[3] Yakura, H. (1994) Crit. Rev. Immunol. (in press). 
[4] Charbonneau, H., Tonks, N.K., Walsh, K.A. and Fischer, E.H. 
(1988) Proc. Natl. Acad. Sci. USA 85, 7182-7186. 
[5] Tonks, N.K., Charbonneau, H., Diltz, C.D., Fischer, E.H. and 
Walsh, K.A. (1988) Biochemistry 27, 8695-8701. 
[6] Saito, H. and Streuli, M. (1991) Cell Growth and Differ. 2, 59 
65. 
[7] Charbonneau, H. and Tonks, N.K. (1992) Annu. Rev. Cell Biol. 
8, 463-493. 
[8] Fischer, E.H., Charbonneau, H. and Tonks, N.K. (1991) Science 
253, 401-406. 
[9] Streuli, M., Krueger, N.X., Hall, L.R., Schlossman, S.F. and 
Saito, H. (1988) J. Exp. Med. 168, 1553 1562. 
[10] Streuli, M., Krueger, N.K., Tsai, A.Y.M. and Saito, H. (1989) 
Proc. Natl. Acad. Sci. USA 86, 8698-8702. 
[11] Streuli, M., Krueger, N.X., Ariniello, P.D., Tang, M., Munro, 
J.M., Blattler, W.A., Adler, D.A., Disteche, C.M. and Saito, H. 
(1992) EMBO J. 11,897-907. 
[12] Mizuno, K., Hasegawa, K., Katagiri, T., Ogimoto, M., Ichikawa, 
T. and Yakura, H. (1993) Mol. Cell. Biol. 13, 5513-5523. 
[13] Jiang, Y.-P., Wang, H., D'Eustachio, P., Musacchio, J.M., 
Schlessinger, J. and Sap, J. (1993) Mol. Cell. Biol. 13, 2942-2951. 
[14] Gebbink, M.F.B.G., van Eyyen, I., Hateboer, G., Suijkerbuijk, R., 
Beijersbergen, R.L., Geurts van Kessel, A. and Moolenaar, W. 
(1991) FEBS Lett. 290, 123-130. 
[15] Walton, K.M., Mrtell, K.J., Kwak, S.P., Dixon, J.E. and Largent, 
B.L. (1993)Neuron 11,387-400. 
[16] Yan, H., Grossman, A., Wang, H., D'Eustachio, P., Mossie, K., 
Musacchio, J.M., Silvennoinen, O. and Schlessinger, J. (1993) 
J. Biol. Chem. 268, 24880-24886. 
228 K. Mizuno et al./FEBS Letters 355 (1994) 223-228 
Fig. 7. In situ hybridization of the SJL mouse spleen (A and B) and thymus (t; and D). Twenty/tm-thick sections were hybridized with DIG-labelled 
antisense (A and C) and sense (B and D) MPTP~ cRNA probes. Note that the medulla of the thymus was heavily labelled (C). f, follicle; c, cortex; 
m, medulla. 
[17] Sap, J., Jiang, Y.-P., Friedlander, D., Grumet, M. and Schlessin- 
ger, J. (1994) Mol. Cell. Biol. 14, 1-9. 
[18] Brady-Kainay, S.M., Flint, A.J. and Tonks, N.K. (1993) J. Cell. 
Biol. 122, 961-972. 
[19] Gebbink, M.F.B.G., Zondag, G.C.M., Wubbolts, R.W., 
Beijersbergen, R.L., van Etten, I. and Moolenaar, W.H. (1993) 
J. Biol. Chem. 268, 16101 16104. 
[20] Swarup, G., Dasgupta, J.D. and Garbers, D.L. (1983) J. Biol. 
Chem. 258, 10341 10347. 
[21] Sorge, L.K., Levy, B.T. and Maness, EF. (1984) Cell 36, 249 257. 
[22] Sudol, M. and Hanafusa, H. (1986) Mol. Cell. Biol. 6, 2839-2846. 
[23] Hirano, A.A., Greengard, P. and Huganir, R.L. (1988) J. Neu- 
rosci. 1447-1455. 
[24] Cordon-Cardo, C., Tapley, P., Jing, S., Nanduri, V., O'Rourke, 
E., Lambelle, F., Kovary, K., Klein, R., Jones, K.R., Reicherdt, 
L.F. and Barbacid, M. (1991) Cell 66, 1-20. 
[25] Kaplan, D.R., Martin-Zanca, D. and Parada, L.F. (1991) Nature 
350, 158 160. 
[26] Klein, R., Jing, S., Nanduri, V., O'Rourke, E. and Barbacid, M. 
(1991) Cell 65, 189 197. 
[27] Chao, M.V. (1992) Neuron 9, 583-593. 
[28] Hatakeyama, M., Kono, T., Kobayashi, N., Kawahara, A., Levin, 
S.D., Perlmutter, R.M. and Taniguchi, T. (1991) Science 252, 
1523-1528. 
[29] Qu, z., Moritz, E. and Huganir, R.L. (1990) Neuron 2, 367-378. 
[30] Williams, A.F. and Barclay, A.N. (1988) Annu. Rev. Immunol. 6, 
381-405. 
[31] Lindner, J., Rathjen, F.G. and Schachner, M. (1983) Nature 305, 
427-430. 
[32] Chuong, C.M., Crossin, K.L. and Edelman, G.M. (1987) J. Cell. 
Biol. 104, 331-342. 
[33] Grenningloh, G., Bieber, A.J., Rehm, E.J., Snow, P.M., Traquina, 
Z.R., Hortsch, M., Patel, N.H. and Goodman, C.S. (1990) Cold 
Spring Harbor Symp. Quant. Biol. 55, 327-340. 
